• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国甲状腺全切除术在乳头状甲状腺癌治疗中的应用。

Utilization of total thyroidectomy for papillary thyroid cancer in the United States.

作者信息

Bilimoria Karl Y, Bentrem David J, Linn John G, Freel Andrew, Yeh Jen Jen, Stewart Andrew K, Winchester David P, Ko Clifford Y, Talamonti Mark S, Sturgeon Cord

机构信息

Department of Surgery, Division of Surgical Oncology, Northwestern University, Chicago, Ill., USA.

出版信息

Surgery. 2007 Dec;142(6):906-13; discussion 913.e1-2. doi: 10.1016/j.surg.2007.09.002. Epub 2007 Nov 5.

DOI:10.1016/j.surg.2007.09.002
PMID:18063075
Abstract

BACKGROUND

Despite guidelines that recommend total thyroidectomy for papillary thyroid cancer (PTC) greater than or equal to 1 cm, the extent of surgery remains controversial. We examined surgical practice patterns for PTC greater than or equal to 1 cm and identified factors that predict the use of total thyroidectomy.

METHODS

Of 90,382 patients in the National Cancer Center Data Base (NCDB) with PTC from 1985 to 2003, 57,243 patients had tumors greater than or equal to 1 cm and underwent total thyroidectomy or lobectomy. Trends in extent of surgery for PTC were examined over 2 decades. Logistic regression was used to identify factors that predict use of total thyroidectomy compared with lobectomy.

RESULTS

Use of total thyroidectomy increased from 70.8% in 1985 to 90.4% in 2003 (P < .0001). Patients were less likely to undergo total thyroidectomy if they were black, older than 45 years, had Medicare, had lower household incomes, or had less education (P < .0001). Moreover, patients treated at high-volume or academic centers were more likely to undergo total thyroidectomy than were patients examined at low-volume or community hospitals (P < .0001).

CONCLUSIONS

Use of total thyroidectomy for PTC greater than or equal to 1 cm increased over time. Differences in use of total thyroidectomy are related to patient, tumor, and hospital factors and likely reflect disparities in access to care.

摘要

背景

尽管指南推荐对直径大于或等于1厘米的乳头状甲状腺癌(PTC)行全甲状腺切除术,但手术范围仍存在争议。我们研究了直径大于或等于1厘米的PTC的手术实践模式,并确定了预测全甲状腺切除术使用情况的因素。

方法

在1985年至2003年国家癌症中心数据库(NCDB)中90382例PTC患者中,57243例患者肿瘤直径大于或等于1厘米,并接受了全甲状腺切除术或甲状腺叶切除术。对20多年来PTC手术范围的趋势进行了研究。采用逻辑回归分析确定与甲状腺叶切除术相比,预测全甲状腺切除术使用情况的因素。

结果

全甲状腺切除术的使用率从1985年的70.8%上升至2003年的90.4%(P <.0001)。黑人、年龄大于45岁、拥有医疗保险、家庭收入较低或受教育程度较低的患者接受全甲状腺切除术的可能性较小(P <.0001)。此外,在高容量或学术中心接受治疗的患者比在低容量或社区医院接受检查的患者更有可能接受全甲状腺切除术(P <.0001)。

结论

随着时间的推移,直径大于或等于1厘米的PTC患者全甲状腺切除术的使用率有所增加。全甲状腺切除术使用情况的差异与患者、肿瘤和医院因素有关,可能反映了医疗服务可及性的差异。

相似文献

1
Utilization of total thyroidectomy for papillary thyroid cancer in the United States.美国甲状腺全切除术在乳头状甲状腺癌治疗中的应用。
Surgery. 2007 Dec;142(6):906-13; discussion 913.e1-2. doi: 10.1016/j.surg.2007.09.002. Epub 2007 Nov 5.
2
Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer.甲状腺切除范围并非低危或高危乳头状甲状腺癌患者生存的主要决定因素。
Ann Surg Oncol. 2005 Jan;12(1):81-9. doi: 10.1007/s10434-004-1165-1. Epub 2004 Dec 27.
3
Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.希腊 1991 年至 2006 年间甲状腺切除术患者甲状腺乳头状癌检出率增高。
Anticancer Res. 2009 Dec;29(12):5163-9.
4
High recurrent rate of multicentric papillary thyroid carcinoma.多中心性乳头状甲状腺癌的高复发率。
Ann Surg Oncol. 2009 Sep;16(9):2609-16. doi: 10.1245/s10434-009-0565-7. Epub 2009 Jun 16.
5
Surgery for papillary thyroid carcinoma: is lobectomy enough?甲状腺乳头状癌手术:肺叶切除术足够了吗?
Arch Otolaryngol Head Neck Surg. 2010 Nov;136(11):1055-61. doi: 10.1001/archoto.2010.181.
6
Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.全甲状腺切除术后对侧甲状腺乳头状癌对放射性碘治疗后的复发或生存无影响。
Surgery. 2006 Dec;140(6):1043-7; discussion 1047-9. doi: 10.1016/j.surg.2006.08.007. Epub 2006 Nov 1.
7
[Total thyroidectomy of choice in papillary microcarcinoma].[甲状腺乳头状微小癌的首选治疗为全甲状腺切除术]
G Chir. 2007 Jan-Feb;28(1-2):13-9.
8
The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size.大小大于或等于4厘米的甲状腺结节中的癌症发病率及细胞学假阴性率。
Surgery. 2007 Dec;142(6):837-44; discussion 844.e1-3. doi: 10.1016/j.surg.2007.08.012. Epub 2007 Nov 5.
9
AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.美国分化型甲状腺癌的AMES预后指数与甲状腺切除范围
Surgery. 2004 Sep;136(3):609-16. doi: 10.1016/j.surg.2003.12.009.
10
Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis.甲状腺乳头状癌患者的最佳治疗策略:一项决策分析
Surgery. 2001 Dec;130(6):921-30. doi: 10.1067/msy.2001.118370.

引用本文的文献

1
Impact of fine-needle aspiration cytology in thyroidectomy extent and associated surgical morbidity in thyroid cancer.细针穿刺细胞学检查对甲状腺癌甲状腺切除范围及相关手术并发症的影响
Langenbecks Arch Surg. 2024 Feb 19;409(1):68. doi: 10.1007/s00423-024-03258-3.
2
Evolving variation in the extent of surgery for low-risk papillary thyroid cancer in the United States.美国低危型甲状腺乳头状癌手术范围演变的差异。
Surgery. 2023 Oct;174(4):828-835. doi: 10.1016/j.surg.2023.07.001. Epub 2023 Aug 6.
3
Prognostic Utility of Tumor Stage versus American Thyroid Association Risk Class in Thyroid Cancer.
肿瘤分期与美国甲状腺协会风险分级在甲状腺癌中的预后价值。
Laryngoscope. 2023 Jan;133(1):205-211. doi: 10.1002/lary.30252. Epub 2022 Jun 18.
4
Age-based disparities in the use of total thyroidectomy for papillary thyroid carcinoma.基于年龄的甲状腺乳头状癌全甲状腺切除术应用差异。
Clin Transl Oncol. 2017 Oct;19(10):1253-1259. doi: 10.1007/s12094-017-1663-9. Epub 2017 Apr 24.
5
National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.非晚期甲状腺髓样癌(MTC)手术治疗的全国趋势:对2009年美国甲状腺协会指南依从性的评估
World J Surg. 2016 Dec;40(12):2930-2940. doi: 10.1007/s00268-016-3643-6.
6
Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?甲状腺乳头状癌的T1亚分类与复发风险相关吗?
Langenbecks Arch Surg. 2016 Mar;401(2):223-30. doi: 10.1007/s00423-016-1399-y. Epub 2016 Mar 8.
7
Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes?分化型甲状腺癌患者甲状腺叶切除术后放射性碘的应用:它会改变治疗结果吗?
J Am Coll Surg. 2015 Apr;220(4):617-25. doi: 10.1016/j.jamcollsurg.2014.12.014. Epub 2014 Dec 17.
8
The relationship between extent of thyroid cancer surgery and use of radioactive iodine.甲状腺癌手术范围与放射性碘的应用之间的关系。
Ann Surg. 2013 Aug;258(2):354-8. doi: 10.1097/SLA.0b013e31826c8915.
9
Variation in the management of thyroid cancer.甲状腺癌的治疗差异。
J Clin Endocrinol Metab. 2013 May;98(5):2001-8. doi: 10.1210/jc.2012-3355. Epub 2013 Mar 28.
10
Referral patterns for patients with high-risk thyroid cancer.高危甲状腺癌患者的转诊模式。
Endocr Pract. 2013 Jul-Aug;19(4):638-43. doi: 10.4158/EP12288.OR.